Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 264

Results For "ENT"

10062 News Found

Former VP M. Venkaiah Naidu praises Wadi Surgicals infrastructure in AMTZ, Visakhapatnam
Medical Device | April 22, 2026

Former VP M. Venkaiah Naidu praises Wadi Surgicals infrastructure in AMTZ, Visakhapatnam

The plant is currently scaling towards a production capacity of nearly 3 million gloves per day


ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche
Clinical Trials | April 22, 2026

ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche

The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents


ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
People | April 22, 2026

ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer

Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations


ECI taps industry veteran Khalid Raja to drive strategic growth
People | April 22, 2026

ECI taps industry veteran Khalid Raja to drive strategic growth

Move comes amid rising regulatory pressures


US FDA okays Merck's new once-daily HIV pill
Drug Approval | April 22, 2026

US FDA okays Merck's new once-daily HIV pill

The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir


Pfizer unleashes wave of breakthrough cancer data at ASCO 2026
R&D | April 22, 2026

Pfizer unleashes wave of breakthrough cancer data at ASCO 2026

Pharma giant targets new standards of care


Asahi Kasei pushes into human trials with new autoimmune drug candidate
Clinical Trials | April 22, 2026

Asahi Kasei pushes into human trials with new autoimmune drug candidate

The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp


Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
Biopharma | April 22, 2026

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform


Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease
Clinical Trials | April 22, 2026

Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease

By cutting pain crises & boosting haemoglobin


Freudenberg Medical launches CleanAssure cleanroom for sterile single-use assemblies
News | April 22, 2026

Freudenberg Medical launches CleanAssure cleanroom for sterile single-use assemblies

It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.